ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

We Be High Releases Free Cannabis Research Series - Enjoy Engaging, Medically Cited Publications Worldwide

Whether you're a journalist in dire need of medically backed, scientifically cited sources on CBD for your new piece, seek objective grading criteria to discover safe, effective, and responsibly-made cannabis, CBD, and hemp products. At We Be High, we're your worldwide friendly passionate individuals in the fields of medicinal research, activism, and overall betterment of society. We believe cannabis can help better the world - but that's not without its caveats. Explore everything from CBD and cannabis in our free new research series!



IRVINE, Calif. - January 15, 2020 - (Newswire.com)

We Be High – a global cannabis news and research portal – is excited to announce an engaging series on the cannabis plant in support of its federal legalization. The new series covers every important aspect related to cannabis, from legal issues to science, news, and lifestyle topics.

"Federal legalization is coming to us sooner than later. Both hemp and marijuana have recently received great support from the American society. We want to prepare a legitimate educational background for everybody in the community, both people who are just entering the market and those who consider themselves seasoned consumers. Our website is based on the latest scientific research, as well as news from mainstream cannabis media. Our aim is to unite the cannabis consumers, not divide them in the classic hemp vs. marijuana way," says Dustin Marin, founder and CEO.

"I couldn’t agree more. Cannabinoids are complicated, and we still have much to discover about the way it affects people despite being in use for almost 10,000 years," says cannabis researcher and consultant Justin Cooke, Editor in Chief at Daily CBD.

"Let's face it, cannabis science is something new to many people. Thirty years ago, hardly anyone knew about the endocannabinoid system, let alone the medical benefits of using cannabis. We can't expect people to understand everything while throwing weird-sounding scientific terms at their faces. We created We Be High to serve you that knowledge in an easily digestible way. The more people begin to understand the basics behind how cannabis affects us, the shorter our road to the federal legalization," emphasizes Cooke.

The engaging news and research series on cannabis allows users to educate themselves using a well-backed source of information, from understanding the plant's effects to its history, medical uses, influence on the contemporary culture to explaining the differences between various forms of cannabis.

To expand the knowledge about cannabis and learn to benefit from using the plant, on the recently released interactive global guides, readers find our series of cannabis news and research.

To keep up with the latest cannabis news and research – We Be High will provide readers with the latest unbiased, medically cited, and easy to consume objective product guides.

​Media Contact: 

Dustin Marin – dustin@webehigh.com


Related Links
CBD Archives - We Be High
Introduction to CBD - We Be High

Related Images




Press Release Service by Newswire.com

Original Source: We Be High Releases Free Cannabis Research Series - Enjoy Engaging, Medically Cited Publications Worldwide
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.